{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":27,"n_cols":5,"rows_kept":27,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[9,2,9,3],[10,2,10,3],[12,2,12,3],[14,2,14,3],[14,4,14,5],[15,2,15,3],[15,4,15,5],[16,2,16,3],[16,4,16,5],[17,2,17,3],[19,2,19,3],[21,2,21,3],[22,2,22,3],[23,2,23,3],[24,2,24,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910832984303321"]
[null,null,"Titolo",null,"EIB Working Paper 2023/03 - : : The effect of EIB operations on private sector lending outside the European Union / / EUROPEAN INVESTMENT BANK"]
[null,null,"Pubbl/distr/stampa",null,"[s.l.] : , : European Investment Bank, , 2023"]
[null,null,"ISBN",null,"9789286155864"]
[{"$nulls":4},"9286155867"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (36 p.)"]
[null,null,"Soggetti",null,"Syndicated loans"]
[{"$nulls":4},"Government lending"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,"Nota di contenuto",null,"The effect of EIB operations on private sector lending outside the European Union -- I. Introduction -- II. Data -- III. Country-level analysis -- A.  Empirical strategy -- B.  Results -- C.  Robustness -- IV. Country-sector-level analysis -- V. Conclusion."]
[null,null,null,"Sommario/riassunto","Does an increase in lending by multinational development banks affect the private lending activity in developing countries? This paper shows that this is indeed the case using data on loans and investments by the EIB in combination with data on syndicated loans. We find that a pronounced increase in EIB operations is followed by a surge in the number and volumes of syndicate loans in countries outside the European Union. Our results suggest that multinational banks can incentivise private sector lending by playing an important role in signalling to private markets that borrowers in emerging and developing countries are safe."]
[null,"2.","Record Nr.",null,"UNINA9910367564003321"]
[null,null,"Autore",null,"Yee Nelson"]
[null,null,"Titolo",null,"Cancer Biomarkers and Targets in Digestive Organs / Nelson Yee, Nikki Lee"]
[null,null,"Pubbl/distr/stampa",null,"MDPI - Multidisciplinary Digital Publishing Institute, 2019"]
[{"$nulls":4},"Basel, Switzerland : , : MDPI, , 2019"]
[null,null,"ISBN",null,"9783039214648"]
[{"$nulls":4},"3039214640"]
[null,null,"Descrizione fisica",null,"1 electronic resource (146 p.)"]
[null,null,"Soggetti",null,"Medicine"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Sommario/riassunto","Identification and development of cancer biomarkers and targets have greatly accelerated progress towards precision medicine in oncology. Studies of tumor biology have not only provided insights into the mechanisms underlying carcinogenesis, but also led to discovery of molecules that have been developed into cancer biomarkers and targets. Multi-platforms for molecular characterization of tumors using next-generation genomic sequencing, immunohistochemistry, in situ hybridization, and blood-based biopsies have greatly expanded the portfolio of potential biomarkers and targets. These cancer biomarkers have been developed for diagnosis, early detection, prognosis, and prediction of treatment response. The molecular targets have been exploited for anti-cancer therapy and delivery of therapeutic agents. This Special Issue of Biomedicines focuses on recent advances in the discovery, characterization, translation, and clinical application of cancer biomarkers and targets in malignant diseases of the digestive system. The goal is to stimulate basic and translational research and clinical collaboration in this exciting field with the hope of developing strategies for prevention and early detection/diagnosis of cancer in digestive organs, and improving therapeutic and psychosocial outcomes in patients with these malignant diseases."]